The Cost Curve, Flu, and Other News
Health & Veritas
Howie and Harlan discuss the outlook for U.S. healthcare spending over the next five years, the state of seasonal and avian flu, and an expensive AI-based cardiac test. Show notes: Life expectancy and expenditures ACOs and cost savings World Prematurity Day AI concerns Bird flu Cardiology and AI Free speech and drug promotion Medicare premiums In the Yale School of Management’s , you’ll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's offers a rigorous public health education for working...
info_outline
Jerry Avorn: Countering the Drug Marketing Machine
Health & Veritas
Howie and Harlan are joined by Harvard internist Jerry Avorn to discuss his research on the pharmaceutical industry and his work promoting evidence-based prescribing. Harlan highlights new results from the American Heart Association meeting, including a one-time CRISPR-based therapy for high cholesterol; Howie reports on an outbreak of infant botulism. Show notes: Research from the American Heart Association Meeting Jerry Avorn Infant Botulism In the Yale School of Management’s , you’ll get a full MBA education in 22 months while applying new skills to your...
info_outline
Ali Rahimi: A Cardiologist in Your Pocket
Health & Veritas
Howie and Harlan are joined by cardiologist Ali Rahimi, the founder of ALYKA Health, which uses a personalized mobile app to help patients manage their heart health between doctor's visits. Harlan discusses new developments in GLP-1 obesity drugs, including untested microdose treatments; Howie reviews a landmark study investigating whether broad prostate cancer screening saves lives. Show notes: GLP-1 Drugs Ali Rahimi New Evidence on Prostate Cancer Screening and Breast Cancer Treatment In the Yale School of Management’s , you’ll get a full MBA education in 22...
info_outline
Nate Wood: Cooking Lessons for Better Health
Health & Veritas
Howie and Harlan are joined by Nate Wood, a Yale School of Medicine internist and trained chef, to discuss his work combining lifestyle guidance with hands-on training in making healthy, tasty food. Harlan shares new guidance on what counts as a healthy blood pressure; Howie provides an update on rising health insurance costs. Links: Blood Pressure Obesity Drugs Culinary Medicine Health Insurance Costs .
info_outline
Akiko Iwasaki: What Have We Learned About Long COVID?
Health & Veritas
Howie and Harlan are joined by Yale School of Medicine immunologist Akiko Iwasaki, a leading authority on vaccines and long COVID. Harlan reflects on America’s crisis of trust in federal agencies; Howie provides some good news about bird flu. Links: Losing Trust Akiko Iwasaki Bird Flu .
info_outline
Rajlakshmi Krishnamurthy: Coordinated Care, Better Care
Health & Veritas
Howie and Harlan are joined by Rajlakshmi Krishnamurthy, the Yale School of Medicine's associate dean for population health, to discuss her work building holistic systems for care at multiple institutions. Harlan discusses healthcare headlines including the launch of "TrumpRX"; Howie reports on a new study taking a novel approach to understanding the impact of the COVID-19 vaccine. Links: Healthcare Headlines Population Health The COVID-19 Vaccine .
info_outline
Crowded Emergency Rooms and Other News
Health & Veritas
Howie and Harlan discuss the roots of the crisis in emergency departments, the lack of oversight for hydration spas, new approaches in blood pressure treatment, an ingenious method to prevent malaria, and the CDC’s backward steps on vaccines. Links: Emergency Departments The Revolving Door Hydration Spas New Developments in Blood Pressure Treatment AI in Medicine: Doximity, OpenEvidence, and UpToDate Congenital syphilis MMR Vaccine Nobel Prizes and Science at Yale .
info_outline
Vanessa Cooper: The Science of Headaches
Health & Veritas
Howie and Harlan are joined by Vanessa Cooper, a Yale School of Medicine neurologist, to discuss the causes of migraines and promising new treatments for the disorder. Harlan discusses his approach as a journal editor to the use of AI in academic writing; Howie reports on the premium tax credits for insurance purchased through Affordable Care Act exchanges that are at stake in the government shutdown. Links: The Government Shutdown Headaches ACA Tax Credits and the Government Shutdown .
info_outline
Kate Heilpern: Jumping into the Deep End
Health & Veritas
Howie and Harlan are joined by Kate Heilpern, president of Yale New Haven Hospital, to discuss the innovation and adaption needed to lead NewYork-Presbyterian Hospital through the worst of the COVID-19 pandemic, and how Yale New Haven Health structures itself to provide quality care across five hospitals. Harlan reflects on the many biotech startups emerging from Yale; Howie responds to the Trump administration's assertion of a link between acetaminophen and autism. Links: Biotech at Yale and Beyond . Kate Heilpern Tylenol and Autism .
info_outline
Barry Wu: The Questions to Ask the Elderly
Health & Veritas
Howie and Harlan are joined by Yale School of Medicine geriatrician Barry Wu, who provides a framework for family caregivers and physicians to understand the needs of older adults. Harlan reports on Congress's shifting approach to funding research; Howie reflects on a survey showing that many college students believe that violence is an acceptable way to protest a campus speaker. Links: Congressional Directives on Funding Research Supporting Older Adults Violence and Speech ACA Subsidies .
info_outlineHowie and Harlan are joined by public health communicator Katelyn Jetelina for updates on COVID-19 and other issues, and to discuss how her emails to students and colleagues in the early days of the pandemic turned into a platform with global reach. Harlan looks at how AI is being used on both sides of the battle between providers and insurers over claims; Howie reports on a setback with a promising gene therapy for Duchenne muscular dystrophy.
Links:
Insurance Claims, AI, and Wearables
“Elevance Health Reports Second Quarter 2025 Results”
“Elevance lowers profit outlook, warns things will get worse for health insurers “
“Blue KC wrongfully denied medical diagnoses, hospital alleges in AI-driven claims lawsuit”
“Oscar Health cuts full-year guidance, estimates 2025 loss as ACA marketplace stumbles”
“WHOOP Delivers Innovative Blood Pressure Insights for a Deeper Look at Your Well-Being”
“Introducing Heart Screener: A smarter way to stay connected to your heart health”
“Whoop says FDA is ‘overstepping its authority’ with warning about blood pressure feature”
FDA: WARNING LETTER, WHOOP, Inc.
“RFK Jr. wants everyone to use wearables. What are the benefits, risks?”
“Apple to Sell Watches With Blood-Oxygen Feature Disabled After Legal Setback”
Your Local Epidemiologist
“Poll: Trust in Public Health Agencies and Vaccines Falls Amid Republican Skepticism”
“Popular epidemiologist lays out future path of public health communication”
Yale School of Public Health: PopHIVE
Katelyn Jetelina: “NIH: The quiet engine of science is being dismantled”
Mayo Clinic: Norovirus infection
Katelyn Jetelina: “The show must go on...”
Katelyn Jetelina: “Harassment against scientists is out of control”
Katelyn Jetelina: “Medicaid cuts: The how and why”
CDC: H5 Bird Flu: Current Situation
CDC: Current Epidemic Trends (Based on Rt) for States”
CDC: Measles Cases and Outbreaks
Treating Duchenne Muscular Dystrophy
Cleveland Clinic: Duchenne Muscular Dystrophy (DMD)
“FDA approves Sarepta’s Duchenne gene therapy for nearly all patients”
“AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial”
“Patient dies in Sarepta gene therapy trial, adding to safety concerns”
“In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy”
“Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks”
Learn more about the MBA for Executives program at Yale SOM.